NCT02163525 2025-09-30
Post Market TRUST - U.S.A. Study
Acessa Health, Inc.
Phase NA Completed
Clinical Trials
25 trialsNCT03271489 2025-07-22
Long-Term Safety Study of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women
AbbVie
Phase 3 Completed
NCT03751124 2024-06-25
Study of Relugolix With Estradiol and Norethindrone Acetate in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids
Myovant Sciences GmbH
Phase 3 Completed
NCT01563783 2023-02-01
TRUST
Acessa Health, Inc.
Phase NA Completed
NCT03103087 2022-04-20
LIBERTY 2: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids
Myovant Sciences GmbH
Phase 3 Completed
NCT03886220 2022-03-31
A Study to Evaluate the Safety and Efficacy of Elagolix for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women
AbbVie
Phase 4 Completed
NCT00731341 2021-07-19
Hysteroscopic Cryomyolysis for the Treatment of Submucosal Leiomyomata
Boston Scientific Corporation
Phase NA Completed
NCT02691494 2021-07-13
Efficacy and Safety of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women (Replicate Study)
AbbVie
Phase 3 Completed
NCT02925494 2021-07-13
An Extension Study to Evaluate the Efficacy and Safety of Elagolix in Premenopausal Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids
AbbVie
Phase 3 Completed
NCT03070899 2021-06-09
PRIMROSE 1
ObsEva SA
Phase 3 Completed
NCT03070951 2021-03-05
PRIMROSE 2
ObsEva SA
Phase 3 Completed
NCT03744507 2020-11-10
Bone Mineral Density in Women With Uterine Fibroids or Endometriosis
Myovant Sciences GmbH
Completed
NCT01817530 2020-07-21
Safety and Efficacy in Premenopausal Women With Heavy Menstrual Bleeding (HMB) Associated With Uterine Fibroids (UF)
AbbVie
Phase 2 Completed
NCT02654054 2020-06-29
Efficacy and Safety of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women
AbbVie
Phase 3 Completed
NCT02228174 2020-02-11
SONATA
Gynesonics
Phase NA Completed
NCT01750008 2018-11-20
LUSTOR
Acessa Health, Inc.
Phase NA Completed
NCT02835391 2017-09-01
PerClot Compared to Usual Care in Gynaecology Procedures
CryoLife Europa
Phase NA Completed
NCT02465814 2016-11-22
ASTEROID 2
Bayer
Phase 2 Completed
NCT00628901 2012-07-11
A Prospective Study Comparing Contour SE™ Microspheres to Embosphere® Microspheres for Treating Symptomatic Uterine Fibroids With Uterine Fibroid Embolization (UFE)
Boston Scientific Corporation
Phase 4 Completed
NCT00152256 2008-05-29
A Study to Evaluate of the Safety and Effectiveness of Asoprisnil in Treating Women With Uterine Fibroids
Abbott
Phase 3 Completed
NCT00152269 2008-05-29
Treatment of Uterine Fibroids With Asoprisnil(J867)
Abbott
Phase 3 Completed
NCT00156195 2008-05-29
Study to Evaluate the Safety of Asoprisnil in the Treatment of Uterine Fibroids
Abbott
Phase 3 Completed
NCT00156208 2008-05-29
Safety of Treatment of Uterine Fibroids With Asoprisnil
Abbott
Phase 3 Completed
NCT00160381 2008-05-29
A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment of Uterine Fibroids
Abbott
Phase 3 Completed
NCT00156156 2008-05-28
Study of Asoprisnil in the Treatment of Uterine Fibroids.
Abbott
Phase 3 Completed